Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Batist

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Cardiovascular Toxicology|July 27, 2007
Cardiac safety of liposomal anthracyclinesGerald Batist
Expert Opinion on Therapeutic Targets|May 8, 2010
Gap junctions and connexins as therapeutic targets in cancerMustapha Kandouz, Gerald Batist
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
AnthracyclinesDavid Hamilton, Gerald Batist
Current Oncology Reports|January 31, 2004
Glutathione analogues in cancer treatmentDavid Hamilton, Gerald Batist
Idrugs : the Investigational Drugs Journal|July 27, 2005
TLK-199 (Telik)David Hamilton, Gerald Batist
Expert Opinion on Drug Discovery|April 25, 2014
Advances in the approach to novel drug clinical development for breast cancerCristiano Ferrario, Gerald Batist
Biochimica Et Biophysica Acta|December 4, 2012
Glutathione and glutathione analogues; therapeutic potentialsJian Hui Wu, Gerald Batist
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 28, 2014
Redefining cancer: a new paradigm for better and faster treatment innovationDavid J Stewart, Gerald Batist
Trends in Cancer|November 27, 2020
Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and TreatmentBruce Gottlieb, Mark Trifiro, Gerald Batist
The New England Journal of Medicine|June 11, 2020
Tofacitinib for Refractory Immune-Related Colitis from PD-1 TherapyKhashayar Esfahani, Marie Hudson, Gerald Batist
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Cardiovascular Toxicology|July 27, 2007
Cardiac safety of liposomal anthracyclinesGerald Batist
Expert Opinion on Therapeutic Targets|May 8, 2010
Gap junctions and connexins as therapeutic targets in cancerMustapha Kandouz, Gerald Batist
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
AnthracyclinesDavid Hamilton, Gerald Batist
Current Oncology Reports|January 31, 2004
Glutathione analogues in cancer treatmentDavid Hamilton, Gerald Batist
Idrugs : the Investigational Drugs Journal|July 27, 2005
TLK-199 (Telik)David Hamilton, Gerald Batist
Expert Opinion on Drug Discovery|April 25, 2014
Advances in the approach to novel drug clinical development for breast cancerCristiano Ferrario, Gerald Batist
Biochimica Et Biophysica Acta|December 4, 2012
Glutathione and glutathione analogues; therapeutic potentialsJian Hui Wu, Gerald Batist
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 28, 2014
Redefining cancer: a new paradigm for better and faster treatment innovationDavid J Stewart, Gerald Batist
Trends in Cancer|November 27, 2020
Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and TreatmentBruce Gottlieb, Mark Trifiro, Gerald Batist
The New England Journal of Medicine|June 11, 2020
Tofacitinib for Refractory Immune-Related Colitis from PD-1 TherapyKhashayar Esfahani, Marie Hudson, Gerald Batist
Pageof 17